Ascendis Pharma A/S
NASDAQ:ASND
Net Margin
Ascendis Pharma A/S
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | DK |
| Market Cap | 7.8B USD |
| Net Margin |
-152%
|
| Country | US |
| Market Cap | 283.9B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 166.4B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 108.9B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 107.3B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 135.2B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 82.2B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 44.9B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 32.3B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 40T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Ascendis Pharma A/S.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Ascendis Pharma A/S's most recent financial statements, the company has Net Margin of -152.4%.
You don't have any saved screeners yet
